Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


First published on July 8, 2008
This version was published on January 1, 2008
Neuro Oncol 2008 10(5):725-733; DOI:10.1215/15228517-2008-033
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
10/5/725    most recent
15228517-2008-033v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawamura, Y.
Right arrow Articles by Fujimaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Clinical Investigations

Role of surgery for optic pathway/hypothalamic astrocytomas in children

Yutaka Sawamura, Kyousuke Kamada, Yuuta Kamoshima, Shigeru Yamaguchi, Toshihiro Tajima, Junko Tsubaki and Takamitsu Fujimaki

Departments of Neurosurgery (Y.S., K.K., Y.K., S.Y.) and Pediatrics (T.T., J.T.), Hokkaido University Hospital, Sapporo; Department of Neurosurgery, Teikyo University Hospital, Tokyo (T.F.); Japan

Address correspondence to Yutaka Sawamura, Department of Neurosurgery, Hokkaido University Hospital, North-15, West-7, Kita-ku, Sapporo 060-8638, Japan (ysawamu{at}med.hokudai.ac.jp).

Optic pathway/hypothalamic pilocytic astrocytomas in children are usually treated with chemotherapy following a surgical biopsy. In this report, we retrospectively considered the role of surgical intervention. In a series of 25 patients without neurofibromatosis type 1, the median age at initial treatment was 3.1 years (range, 0–15 years). Twenty cases were verified by histology, and five cases were diagnosed by MRI findings. Twenty-three patients received chemotherapy. All patients were alive at median follow-up of 66 months. Aims of surgery at the initiation of treatment were biopsy in 12 cases (1 stereotactic and 11 craniotomies) and debulking in 7 cases. The 11 open biopsies revealed pilocytic astrocytoma; however, noticeable complications occurred in five children after the biopsies. Review of preoperative MRIs showed that all had typical findings indicating pilocytic astrocytoma. The open biopsy offered no noteworthy benefit for the patients despite surgical risk and delay of chemotherapy. The extent of the seven resection surgeries was 70% or less removal, and postoperative adjuvant therapy was needed for six of the seven patients. The remaining six children who did not undergo surgery obtained remission with chemotherapy alone. After relapse in nine patients, 15 bulk-reduction surgeries were performed. Surgical resection was not curative in any patient. In five patients, mostly older children, cystic expansion of tumor was partially resected, resulting in additional remission. In conclusion, considering the risk of open surgery and the effectiveness of chemotherapy, the role of surgical intervention is restricted to bulk-reduction surgery only when it is inevitable, especially at relapse after chemotherapy.

Key Words: biopsy • hypothalamus • optic pathway • pilocytic astrocytoma • surgical removal







  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2008 by Society for Neuro-Oncology